Teprotumumab (Anti-IGF-1R / CD221)
Product Specifications
CAS Number
1036734-93-6
Target
IGF-1R
Applications
Protein Tyrosine Kinase
Additionnal Information
Teprotumumab (Anti-IGF-1R / CD221) is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab can be used for thyroid-associated ophthalmopathy research.MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041081-500 1x 500 µL
CD45RO (190-2F2.5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471003-500 1x 500 µL
Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940809-100 1x 100 µL
Cyclin D1 (CCND1/809), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880774-100 1x 100 µL
HSP27 (HSPB1/774), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details